Skip to content

NeoGenomics NEO Free cash flow margin

Free cash flow margin at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
9.8%+1.0pp
Quest Diagnostics logo
Quest DiagnosticsDGX
11.8%+1.4pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-131.2%-453pp
Guardant Health logo
Guardant HealthGH
-22%-6.7pp
Natera, Inc. logo
Natera, Inc.NTRA
4.2%-0.5pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-54.5%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B-21.0%
Enterprise value$1.6B-5.6%
P/S2.3×-0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Calculated from NeoGenomics’s reported figures.

Based on trailing twelve months.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's free cash flow margin?
NeoGenomics (NEO) reported free cash flow margin of -4.9% in Q1 2025.
What is the long-term trend for NeoGenomics's free cash flow margin?
Over 3 years (2020 to 2024), NeoGenomics's free cash flow margin has grown at a -5.3% compound annual growth rate (CAGR), from -6.2% to -5.3%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.